ADC Therapeutics SA (ADCT) Free cash flow 2022–2025
ADC Therapeutics SA (ADCT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$141.4MFY2025 · since FY2022: -$139.0M → -$141.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$141.4M | -13.4% |
| FY2024 | -$124.7M | -2.3% |
| FY2023 | -$121.9M | +12.3% |
| FY2022 | -$139.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADCT financial trends
ADCT RevenueADCT Net incomeADCT Net marginADCT Gross profitADCT Gross marginADCT Operating incomeADCT Operating marginADCT Operating cash flowADCT Capital expendituresADCT Return on equityADCT Stock buybacksADCT Dividends paidADCT Total assetsADCT Total liabilitiesADCT Shareholders’ equityADCT overview →